Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers (Q30498444)

10 August 2017

Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers (English)

1 reference

10 August 2017

1 reference

Jordi Riba

1

1 reference

ORCID Public Data File 2021

author name string

Peter Anderer

2

1 reference

10 August 2017

Adelaida Morte

3

1 reference

10 August 2017

Gloria Urbano

4

1 reference

10 August 2017

Francesc Jané

5

1 reference

10 August 2017

Bernd Saletu

6

1 reference

10 August 2017

Manel J Barbanoj

7

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

British Journal of Clinical Pharmacology

10 August 2017

1 reference

10 August 2017

53

1 reference

10 August 2017

6

1 reference

10 August 2017

613-628

1 reference

Effects of Ayahuasca on the human EEG.

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874340

Pharmacokinetics of Hoasca alkaloids in healthy humans

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874340

Ayahuasca preparations and serotonin reuptake inhibitors: a potential combination for severe adverse interactions

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874340

Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptors

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874340

Indoleamine and the phenethylamine hallucinogens: mechanisms of psychotomimetic action.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874340

Quantitation of N,N-dimethyltryptamine and harmala alkaloids in human plasma after oral dosing with ayahuasca

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874340

Human psychopharmacology of N,N-dimethyltryptamine

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874340

Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874340

Action of hallucinogens on electroencephalograms

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874340

Clinical studies and quantitative EEG data in experimental psychoses

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874340

On acute and chronic CNS effects of antidepressants in normals: neurophysiological, behavioral and pharmacokinetic studies with pirlindol.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874340

Topographic brain mapping of EEG in neuropsychopharmacology--Part I. Methodological aspects.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874340

Descriptive data analysis: a concept between confirmatory and exploratory data analysis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874340

A comparison of the central nervous system effects of haloperidol, chlorpromazine and sulpiride in normal volunteers

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874340

Statistical aspects of neurophysiologic topography

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874340

Artifact processing in topographic mapping of electroencephalographic activity in neuropsychopharmacology

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874340

“Ayahuasca,” the South American hallucinogenic drink: An ethnobotanical and chemical investigation

20 June 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2002.01609.X

Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2002.01609.X

Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2002.01609.X

Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2002.01609.X

Psychometric assessment of the Hallucinogen Rating Scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2002.01609.X

IPEG guideline on statistical design and analysis for pharmacodynamic trials. International Pharmaco-EEG Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2002.01609.X

5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]raclopride.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.2002.01609.X

Clinical-pharmacological study with the two isomers (d-, l-) of fenfluramine and its comparison with chlorpromazine and d-amphetamine: blood levels, EEG mapping and safety evaluation.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874340

Central and autonomic nervous system side effects of ketanserin

26 November 2018

1 reference

12 December 2020

A solution for reliable and valid reduction of ocular artifacts, applied to the P300 ERP

1 reference

12 December 2020

Characterization of eight biogenic indoleamines as substrates for type A and type B monoamine oxidase

1 reference

12 December 2020

Pharmacokinetic-pharmacodynamic modeling of risperidone effects on electroencephalography in healthy volunteers

1 reference

12 December 2020

10.1046/J.1365-2125.2002.01609.X

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

1 reference